Intec Pharma Ltd., a clinical─stage biopharmaceutical company, announced that the Accordion Pill developed for a proprietary Novartis compound is continuing into a clinical PK study under the previously
More From BioPortfolio on "Intec Pharma to continue development collaboration with Novartis to next phase"